Clinical Trial: Special Investigation Of Azithromycin IV For Legionnaires' Disease (Regulatory Post Marketing Commitment Plan)
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Zithromac Iv Special Investigation For Legionella Infection.
Brief Summary: To collect retrospectively the efficacy and safety information of azithromycin IV on patients with Legionnaires' disease related to their appropriate use in daily practice.
Detailed Summary:
Sponsor: Pfizer
Current Primary Outcome: Number of Participants with Clinical Response of Cure at the Test-of-Cure (TOC) Visit [ Time Frame: 29 days ]
Original Primary Outcome: Number of Participants with Clinical Response of Cure at the Test-of-Cure (TOC) Visit [ Time Frame: 29 days ]
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Pfizer
Dates:
Date Received: February 4, 2013
Date Started: March 2013
Date Completion:
Last Updated: February 23, 2017
Last Verified: February 2017